RYTM:NASDAQ, Rhythm Pharmaceuticals, Inc.

RYTM stock overview

Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ) closed at $107.48 on November 16, 2026, down 6.56% on the day. The stock trades 12.0% below its 52-week high of $122.20 and 44.3% above its 52-week low of $74.50. Over the past year, it gained 6.7%. Rhythm Pharmaceuticals, Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$107.48
Day change
-6.56%
Volume
947,267
Average volume
1,008,140
Market cap
7B+
52-week range
$74.50 – $122.20
50-day average
$96.88
200-day average
$97.24

Price action over the past year

In 252 trading sessions since November 14, 2025, RYTM closed higher on 127 days (50%). Its best day was November 4, 2026 (+28.04%) and its worst was November 3, 2026 (-7.49%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

RYTM news

About Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.

Similar stocks

Find more stocks like RYTM with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.